Medicines for Children Research Network (MCRN)
The National Institute for Health Research (NIHR) Medicines for Children Research Network (MCRN) has been created to improve the co-ordination, speed and quality of randomised controlled trials and other well designed studies of medicines for children and adolescents, including those for prevention, diagnosis and treatment.
The Network has extensive knowledge and experience of paediatric research, and supports non-commercial, pharmaceutical/biotech-sponsored and investigator-led partnership studies in over 100 NHS sites in England that serve approximately 6 million children. The MCRN supports studies through its infrastructure, which includes the MCRN Coordinating Centre, Local Research Networks (LRNs), Clinical Studies Groups (CSGs), Clinical Trial Units (CTUs) and a Neonatal Network.
The MCRN Coordinating Centre is led by a consortium comprising the University of Liverpool, Royal Liverpool Children’s Hospital, Imperial College London, National Perinatal Epidemiology Unit (NPEU; University of Oxford), Liverpool Women’s Hospital and the National Children’s Bureau.
The NIHR MCRN is funded by the Department of Health and works in partnership with the UK Clinical Research Network (UKCRN) to improve the
Website: Link
